|
Excorp Medical
has developed a bioartificial liver system for the temporary metabolic support
of patients in serious liver failure. The bioartificial liver will be used to
sustain a patient until recovery of native liver function or until a transplant
becomes possible. This is the first such system, worldwide, which has been used
successfully in both controlled animal studies and in human clinical trials. As
many as 350,000 patients could benefit from bioartificial liver support annually
in the US with a comparable number in the European Community. Worldwide, the
number of patients is much larger due in part to the prevalence of viral
hepatitis.
www.excorp.com
PlaCor is a development stage company with proprietary
technology for measuring the effect of anti-platelet drugs. The
company was formed in 2003 by four former executives from AVECOR
Cardiovascular, Inc. to further develop a novel device to
measure platelet reactivity. In the US alone, tens of millions
of people take aspirin and other anti-platelet drugs daily to
prevent heart attacks and strokes. Testing to ensure that these
drugs are indeed working is a large, emerging market area. The
company has raised over $1.6 million in initial financing and is
now seeking an additional $2.5 million (or greater) in 2005.
Proceeds will be used to complete product development, finish
laboratory and clinical studies and obtain 510(k) approval.
Commercial launch is expected early in 2006.
www.placorinc.com
Minnesota Wire & Cable is a
vertically integrated custom manufacturer of wire and cable assemblies for the
Instrumentation, Medical, Defense, and Telecommunications industries. Its
30,000-sq.-ft. headquarters is located in St. Paul, Minnesota, with another
27,000-sq-ft. facility located in Eau Claire, Wisconsin. MWCC is ISO 13485:1996
certified and its capabilities include custom tooling, cable extrusion,
engineering and design, as well as shielding and cabling.
www.mnwire.com
|
...
by Matt Noah
